$BCRD
BlueOne Card, Inc. Stock $bcrd

$bcrd Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223027842 Filed on August 11, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023 Q1
Revenue	$3.000K		$25.00K
YoY Change
Cost Of Revenue	$1.200K		$40.39K
YoY Change
Gross Profit	$1.800K		-$15.39K
YoY Change
Gross Profit Margin	60.0%		-61.56%
Selling, General & Admin	$413.5K	$320.8K	$403.0K
YoY Change	203.15%	-16.82%	260.71%
% of Gross Profit	22971.67%
Research & Development	$17.64K	$0.00
YoY Change		-100.0%
% of Gross Profit	980.0%
Depreciation & Amortization	$28.75K	$18.03K	$6.480K
YoY Change	254.21%	58.35%	-40.06%
% of Gross Profit	1597.28%
Operating Expenses	$425.4K	$323.5K	$403.0K
YoY Change	201.86%	-19.71%	260.71%
Operating Profit	-$423.6K	-$323.5K	-$418.4K
YoY Change	200.58%	-19.71%	274.49%
Interest Expense	$24.00	$17.00	-$1.420K
YoY Change	-97.94%	-98.81%	144.83%
% of Operating Profit
Other Income/Expense, Net	$8.340K	$576.00
YoY Change	-814.65%	-140.45%
Pretax Income	-$415.2K	-$322.9K	-$439.3K
YoY Change	192.24%	-20.14%	225.76%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$415.2K	-$322.9K	-$439.3K
YoY Change	192.24%	-20.14%	225.76%
Net Earnings / Revenue	-13841.2%		-1757.04%
Basic Earnings Per Share	-$0.03	-$0.03
Diluted Earnings Per Share	-$0.03	-$0.03	-$0.04
COMMON SHARES
Basic Shares Outstanding	12.03M shares	11.39M shares	10.34M shares
Diluted Shares Outstanding	12.03M shares	11.39M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$596.4K	$1.240M	$668.1K
YoY Change	2898.54%	920.49%	1516.94%
Cash & Equivalents	$596.4K	$1.240M	$668.1K
Short-Term Investments
Other Short-Term Assets	$6.760K	$6.760K	$7.050K
YoY Change	-97.7%	-97.7%	-97.39%
Inventory	$73.30K	$74.50K	$74.50K
Prepaid Expenses	$6.759K	$6.759K	$7.048K
Receivables
Other Receivables
Total Short-Term Assets	$676.5K	$1.322M	$749.7K
YoY Change	115.37%	217.9%	140.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$314.1K	$223.8K	$95.69K
YoY Change	421.21%	80.64%	-29.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.390K	$4.390K
YoY Change
Total Long-Term Assets	$947.3K	$623.8K	$241.6K
YoY Change	702.99%	403.48%	78.57%
TOTAL ASSETS
Total Short-Term Assets	$676.5K	$1.322M	$749.7K
Total Long-Term Assets	$947.3K	$623.8K	$241.6K
Total Assets	$1.624M	$1.945M	$991.3K
YoY Change	275.81%	260.51%	121.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$636.4K	$532.6K	$477.7K
YoY Change	916.91%	1248.77%	1121.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$662.1K	$558.4K	$503.4K
YoY Change	53.76%	43.38%	61.46%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$56.82K	$67.08K	$24.86K
YoY Change	68.06%
Total Long-Term Liabilities	$56.82K	$67.08K	$24.86K
YoY Change	68.06%	65.63%	-43.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$662.1K	$558.4K	$503.4K
Total Long-Term Liabilities	$56.82K	$67.08K	$24.86K
Total Liabilities	$719.0K	$625.5K	$528.3K
YoY Change	54.8%	45.47%	48.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.997M	-$2.582M	-$2.259M
YoY Change	77.72%	67.18%	98.16%
Common Stock	$12.03K	$12.03K	$10.34K
YoY Change	17.07%	17.07%	3.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$904.8K	$1.320M	$462.9K
YoY Change
Total Liabilities & Shareholders Equity	$1.624M	$1.945M	$991.3K
YoY Change	275.81%	260.51%	121.7%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$415.2K	-$322.9K	-$439.3K
YoY Change	192.24%	-20.14%	225.76%
Depreciation, Depletion And Amortization	$28.75K	$18.03K	$6.480K
YoY Change	254.21%	58.35%	-40.06%
Cash From Operating Activities	-$282.0K	-$273.2K	-$47.66K
YoY Change	177.37%	206.42%	-70.79%
INVESTING ACTIVITIES
Capital Expenditures	$362.0K	$194.6K	$28.70K
YoY Change			-312.59%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$362.0K	-$334.6K	-$28.70K
YoY Change			112.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.180M
YoY Change		584.06%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$1.180M	617.7K
YoY Change		596.68%	1114.27%
NET CHANGE
Cash From Operating Activities	-282.0K	-$273.2K	-47.66K
Cash From Investing Activities	-362.0K	-$334.6K	-28.70K
Cash From Financing Activities	0.000	$1.180M	617.7K
Net Change In Cash	-644.0K	$572.3K	541.3K
YoY Change	533.41%	613.3%	-530.32%
FREE CASH FLOW
Cash From Operating Activities	-$282.0K	-$273.2K	-$47.66K
Capital Expenditures	$362.0K	$194.6K	$28.70K
Free Cash Flow	-$644.0K	-$467.7K	-$76.36K
YoY Change		424.67%	-48.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001496690
CY2023Q2	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	BCRD	Stock Subscription Received StockSubscriptionReceived		usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2023Q2	BCRD	Cost Of Sales Inventory Reserve CostOfSalesInventoryReserve		usd
CY2023Q2	us-gaap	Gross Profit GrossProfit		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense		usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q2	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits		usd
CY2022Q2	BCRD	Increase Decrease In Compensation Payable IncreaseDecreaseInCompensationPayable		usd
CY2023Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2022Q2	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware		usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q2	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2022Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q2	BCRD	Sale Of Vehicle SaleOfVehicle		usd
CY2022Q2	BCRD	Sale Of Vehicle SaleOfVehicle		usd
CY2022Q2	BCRD	Present Value Of Initial Lease Liability And Rightofuse Asset PresentValueOfInitialLeaseLiabilityAndRightofuseAsset		usd
CY2023Q2	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization		usd
CY2023Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization		usd
CY2023Q2	dei	Document Type DocumentType	10-Q
CY2023Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity File Number EntityFileNumber	000-56060
CY2023Q2	dei	Entity Registrant Name EntityRegistrantName	BlueOne Card, Inc
CY2023Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-0478989
CY2023Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	4695 MacArthur Court
CY2023Q2	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1100
CY2023Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Newport Beach
CY2023Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92660
CY2023Q2	dei	City Area Code CityAreaCode	(800)
CY2023Q2	dei	Local Phone Number LocalPhoneNumber	210-9755
CY2023Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12033704	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1240407	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	668118	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	74500	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	74500	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6759	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7048	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1321666	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	749666	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	223816	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47287	usd
CY2023Q2	BCRD	Software Development Net SoftwareDevelopmentNet	285893	usd
CY2023Q1	BCRD	Software Development Net SoftwareDevelopmentNet	145892	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	109721	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	48401	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4392	usd
CY2023Q2	us-gaap	Assets Assets	1945488	usd
CY2023Q1	us-gaap	Assets Assets	991246	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	69157	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	79543	usd
CY2023Q2	BCRD	Compensation Payable CompensationPayable	426125	usd
CY2023Q1	BCRD	Compensation Payable CompensationPayable	380750	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37350	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17384	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	558397	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	503442	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	67078	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24862	usd
CY2023Q2	us-gaap	Liabilities Liabilities	625475	usd
CY2023Q1	us-gaap	Liabilities Liabilities	528304	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	292000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	292000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	292000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	292000	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	292	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	292	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12033704	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12033704	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10336004	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10336004	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	12034	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	10336	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3889228	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2093226	usd
CY2023Q1	BCRD	Stock Subscription Received StockSubscriptionReceived	617700	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2581541	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2258612	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1320013	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	462942	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1945488	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	991246	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2709	usd
CY2022Q2	us-gaap	Legal Fees LegalFees	17251	usd
CY2023Q2	BCRD	Rent Expense RentExpense	37789	usd
CY2022Q2	BCRD	Rent Expense RentExpense	20337	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	283007	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	365332	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	323505	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	402920	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-323505	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-402920	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	593	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	17	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	1424	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	576	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1424	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-322929	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-404344	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-322929	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-404344	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11392159	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11392159	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10228696	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10228696	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11392159	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10228696	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	462942	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1180000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-322929	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1320013	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	91541	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	172500	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	250000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-404344	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	109697	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-322929	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-404344	usd
CY2023Q2	us-gaap	Depreciation Depreciation	18026	usd
CY2022Q2	us-gaap	Depreciation Depreciation	11384	usd
CY2023Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-862	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	250000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-289	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	23700	usd
CY2023Q2	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-4392	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10386	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	393	usd
CY2023Q2	BCRD	Increase Decrease In Compensation Payable IncreaseDecreaseInCompensationPayable	45375	usd
CY2022Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	77124	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-273155	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-89143	usd
CY2023Q2	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	140001	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	194555	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-334556	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1180000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	172500	usd
CY2022Q2	us-gaap	Repayments Of Debt RepaymentsOfDebt	3126	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1180000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	169374	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	572289	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	80231	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	668118	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41318	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1240407	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	121549	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	3510	usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	1424	usd
CY2023Q2	BCRD	Present Value Of Initial Lease Liability And Rightofuse Asset PresentValueOfInitialLeaseLiabilityAndRightofuseAsset	70844	usd
CY2023Q2	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_800_eus-gaap--NatureOfOperations_zxOIUH14r7Rh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_826_ziDJ3Pie0ig2">NATURE OF OPERATIONS, GOING CONCERN AND BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">General</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BlueOne Card, Inc. (the “Company”) was incorporated on July 6, 2007 under the laws of the state of Nevada. The Company provides innovative payout solutions and prepaid debit card and gift card solutions to consumers and corporations transforming card-to-card cross border real time global money transfers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Risk and Uncertainty Concerning COVID-19 Pandemic</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The global COVID-19 pandemic continues to present uncertainty and unforeseeable risks to the Company’s operations and business plan. The Company has closely monitored recent developments, including the lifting of COVID-19 safety measures, the spread of new strains or variants of the coronavirus (such as the Delta and Omicron variants), and supply chain and labor shortages. Thus, the full impact of the COVID-19 pandemic on the business and operations remains uncertain and will vary depending on the pandemic’s future impact on the third parties with whom the Company does business, as well as any legal or regulatory consequences resulting therefrom. The Company has been following the recommendations of health authorities to minimize exposure risk for its team members and may take further actions that alter our operations, including any required by federal, state or local authorities, or that it determines are in the best interests of its employees and other third parties with whom the Company does business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The interim condensed financial statements have been prepared on a going concern basis which contemplates the realization of assets and settlement of liabilities and commitments in the normal course of business. The Company has not yet generated any significant revenues and has suffered operating losses since July 6, 2007 (Inception Date) to date. The Company recorded a net loss of $<span id="xdx_90E_eus-gaap--NetIncomeLoss_iN_di_c20230401__20230630_zJztm8saqwbg" title="Net income loss">322,929</span>, and used net cash flows in operating activities of $<span id="xdx_90B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230401__20230630_znp6gbMf51Pf" title="Net cash provided by (used in) operating activities">273,155</span> during the three months ended June 30, 2023, and has an accumulated deficit of $<span id="xdx_901_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20230630_z1aSQWmmDHAk" title="Accumulated deficit">2,581,541</span> as of June 30, 2023. These factors, among others, raise a substantial doubt regarding the Company’s ability to continue as a going concern operation for a period of 12 months from the issuance date of these condensed financial statements. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary financing to continue operations, and the attainment of profitability. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying interim condensed financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The interim unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), and include the accounts of the Company. The preparation of interim condensed financial statements requires management to make assumptions and estimates that impact the amounts reported. The interim condensed financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. These interim condensed financial statements, reflect all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of the Company’s results of operations, financial position and cash flows for the interim periods ended June 30, 2023 and 2022; however, certain information and footnote disclosures normally included in our audited annual financial statements, as included in the Company’s interim condensed financial statements, have been condensed or omitted pursuant to such SEC rules and regulations and accounting principles applicable for interim periods. These unaudited condensed financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2023, filed with the SEC on July 14, 2023. It is important to note that the Company’s results of operations and cash flows for interim periods are not necessarily indicative of the results of operations and cash flows to be expected for a full fiscal year or any other interim period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BLUEONE CARD, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-322929	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-273155	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2581541	usd
CY2023Q2	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_znkHwGdYL0je" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zzxiuBiBBuhh">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of its assets, liabilities, equity and operations. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about its estimates that are not readily apparent from other sources. Significant estimates in the accompanying financial statements include the valuation of inventory, software development costs, lease liabilities and right-of-use assets, stock-based compensation and deferred tax assets. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q2	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zdPvr9qZNBD9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zUrMTymEpA7g">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash Concentration</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash is maintained at one financial institution and at times, balances may exceed federally insured limits. We have not experienced any losses related to these balances. As of June 30, 2023, the Company had balances in a financial institution which exceeded federally insured limits by approximately $<span id="xdx_904_eus-gaap--CashFDICInsuredAmount_iI_c20230630_zR29x9KDiv92" title="Cash, FDIC insured amount">990,000</span>. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operation and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Vendor and Concentration</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company relies solely on one vendor for key components and processing services related to the manufacturing, distribution and servicing of its prepaid debit cards and gift cards. The same vendor is also the sole developer and provider of the software for Company’s operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	990000	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	26385	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	26385	usd
CY2023Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2023Q2	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2022Q2	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2240	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-322929	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-404344	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11392159	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11392159	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10228696	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10228696	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	292000000	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	292000000	shares
CY2023Q2	us-gaap	Other Inventory OtherInventory	100885	usd
CY2023Q1	us-gaap	Other Inventory OtherInventory	100885	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	26385	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	26385	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	74500	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	74500	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	320574	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	126019	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	96758	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	78732	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	223816	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47287	usd
CY2023Q2	us-gaap	Depreciation Depreciation	18026	usd
CY2022Q2	us-gaap	Depreciation Depreciation	11384	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	145892	usd
CY2023Q2	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	140001	usd
CY2023Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	285893	usd
CY2023Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	145892	usd
CY2023Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	285893	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	145892	usd
CY2023Q2	us-gaap	Officers Compensation OfficersCompensation	45375	usd
CY2022Q2	us-gaap	Officers Compensation OfficersCompensation	41250	usd
CY2023Q2	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-07-11
CY2023Q2	us-gaap	Payments For Rent PaymentsForRent	37789	usd
CY2022Q2	us-gaap	Payments For Rent PaymentsForRent	20337	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12033704	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10336004	shares
CY2023Q2	us-gaap	Debt Instrument Convertible Liquidation Preference Per Share DebtInstrumentConvertibleLiquidationPreferencePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	292000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	292000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	292000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	292000	shares

Files In Submission

Name	View Source	Status
0001493152-23-027842-index-headers.html	Edgar Link	pending
0001493152-23-027842-index.html	Edgar Link	pending
0001493152-23-027842.txt	Edgar Link	pending
0001493152-23-027842-xbrl.zip	Edgar Link	pending
bcrd-20230630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
bcrd-20230630_cal.xml	Edgar Link	unprocessable
bcrd-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bcrd-20230630_lab.xml	Edgar Link	unprocessable
bcrd-20230630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BCRD
BlueOne Card, Inc. Stock $bcrd

2023 Q3 Form 10-Q Financial Statement

#000149315223027842 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BCRD BlueOne Card, Inc. Stock $bcrd

2023 Q3 Form 10-Q Financial Statement

#000149315223027842 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BCRD
BlueOne Card, Inc. Stock $bcrd